AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
124.95
+1.10 (0.89%)
Jan 30, 2026, 4:00 PM EST - Market closed
AptarGroup Revenue
AptarGroup had revenue of $961.13M in the quarter ending September 30, 2025, with 5.70% growth. This brings the company's revenue in the last twelve months to $3.66B, up 2.50% year-over-year. In the year 2024, AptarGroup had annual revenue of $3.58B with 2.74% growth.
Revenue (ttm)
$3.66B
Revenue Growth
+2.50%
P/S Ratio
2.26
Revenue / Employee
$271,299
Employees
13,500
Market Cap
8.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.58B | 95.44M | 2.74% |
| Dec 31, 2023 | 3.49B | 165.20M | 4.97% |
| Dec 31, 2022 | 3.32B | 95.03M | 2.94% |
| Dec 31, 2021 | 3.23B | 297.88M | 10.17% |
| Dec 31, 2020 | 2.93B | 69.61M | 2.43% |
| Dec 31, 2019 | 2.86B | 94.97M | 3.44% |
| Dec 31, 2018 | 2.76B | 295.48M | 11.97% |
| Dec 31, 2017 | 2.47B | 138.35M | 5.94% |
| Dec 31, 2016 | 2.33B | 13.79M | 0.59% |
| Dec 31, 2015 | 2.32B | -280.66M | -10.80% |
| Dec 31, 2014 | 2.60B | 77.80M | 3.09% |
| Dec 31, 2013 | 2.52B | 188.98M | 8.11% |
| Dec 31, 2012 | 2.33B | -6.15M | -0.26% |
| Dec 31, 2011 | 2.34B | 260.46M | 12.54% |
| Dec 31, 2010 | 2.08B | 235.10M | 12.77% |
| Dec 31, 2009 | 1.84B | -230.07M | -11.11% |
| Dec 31, 2008 | 2.07B | 179.52M | 9.49% |
| Dec 31, 2007 | 1.89B | 290.78M | 18.16% |
| Dec 31, 2006 | 1.60B | 221.38M | 16.04% |
| Dec 31, 2005 | 1.38B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Baxter International | 11.02B |
| Solventum | 8.40B |
| Avantor | 6.58B |
| Bausch + Lomb | 4.98B |
| Hologic | 4.13B |
| The Cooper Companies | 4.09B |
| Align Technology | 3.98B |
| Teleflex | 3.19B |
ATR News
- 9 days ago - Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details - Business Wire
- 10 days ago - Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment - Business Wire
- 17 days ago - AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 24 days ago - Aptar Announces 2026 Quarterly Conference Call Dates - Business Wire
- 26 days ago - Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Business Wire
- 6 weeks ago - Aptar's Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT) - Business Wire
- 2 months ago - Aptar Named One of America's Most Responsible Companies by Newsweek for the Seventh Consecutive Year - Business Wire
- 2 months ago - Aptar Strengthens Latin America Footprint With Sommaplast Buy - Benzinga